1. Home
  2. WDFC vs TNGX Comparison

WDFC vs TNGX Comparison

Compare WDFC & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WD-40 Company

WDFC

WD-40 Company

HOLD

Current Price

$248.33

Market Cap

3.0B

Sector

Industrials

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$31.47

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WDFC
TNGX
Founded
1953
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.9B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
WDFC
TNGX
Price
$248.33
$31.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
$270.00
$21.78
AVG Volume (30 Days)
138.9K
5.5M
Earning Date
04-09-2026
05-08-2026
Dividend Yield
1.91%
N/A
EPS Growth
30.92
26.89
EPS
2.78
N/A
Revenue
$488,109,000.00
$62,384,000.00
Revenue This Year
$8.23
N/A
Revenue Next Year
$5.85
N/A
P/E Ratio
$88.51
N/A
Revenue Growth
19.49
48.29
52 Week Low
$175.38
$4.80
52 Week High
$253.24
$34.39

Technical Indicators

Market Signals
Indicator
WDFC
TNGX
Relative Strength Index (RSI) 77.57 58.74
Support Level $189.99 $19.74
Resistance Level $250.04 $34.39
Average True Range (ATR) 6.76 2.49
MACD 3.22 -0.05
Stochastic Oscillator 95.37 48.50

Price Performance

Historical Comparison
WDFC
TNGX

About WDFC WD-40 Company

WD-40 Co is a global marketing organization focused on developing and selling products that solve maintenance and cleaning problems internationally. It offers two product groups: maintenance products, including the flagship WD-40 Multi-Use Product, which serves as a lubricant, rust preventative, penetrant, and moisture displacer, marketed globally; and homecare and cleaning products, mainly sold in North America, the UK, and Australia. The company distributes its products through hardware stores, automotive parts outlets, industrial suppliers, mass retailers, online platforms, and specialty retailers across the Americas, EIMEA, and Asia-Pacific, with the majority of revenue generated in the Americas.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: